INDIAGLYCO NSE filing

India Glycols faces ₹10.39 crore tax appeal from CGST; company confident of favorable outcome

The RealCase readMedium impact Neutral

Why it matters

The appeal involves a significant financial implication of ₹10.39 crore in potential Central Excise Duty, but the company has a prior favorable ruling from CESTAT, which lessens the immediate high risk, making the overall impact medium.

The market read

An appeal has been filed against the company regarding a tax dispute, which introduces legal uncertainty. However, the company is confident the demand is not maintainable as a previous tribunal ruling was in its favor, balancing the sentiment.

India Glycols Limited has announced that the Commissioner of CGST & Central Excise, Uttarakhand, has filed an appeal before the Hon'ble High Court of Uttarakhand at Nainital. * The appeal challenges an order passed by the Customs, Excise & Service Tax Appellate Tribunal (CESTAT), New Delhi, which had set aside the Commissioner's earlier order dated 9th May 2019. * The litigation pertains to the classification of 'RAB' under the Central Excise Tariff for the financial years 2005 to 2009. * CESTAT had previously adjudicated this matter in favor of India Glycols Limited. * The potential financial implication, if the appeal were to go against the company, includes Central Excise Duty amounting to ₹10,39,32,564 (approximately ₹10.39 crore), along with applicable interest and penalty. * While the company has not yet received an official notice from the High Court, it was informed by its consultant after the matter appeared on the Court’s website. * India Glycols Limited, following discussions with experts, believes that the demand is not maintainable, given the prior favorable order from CESTAT.

Filing to action

What to do with a filing like this

India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under legal. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.

View original filing